Repurposing SARS CoV 2 ligands identifies salvianolic acid C as potential antiviral candidate against human metapneumovirus through computational study
Pallavi Mosale Shanthappa, Nidheesh Melethadathil, Shiva Prasad Kollur · 2025
Read Repurposing SARS CoV 2 ligands identifies salvianolic acid C as potential antiviral candidate against human metapneumovirus through computational study by Pallavi Mosale Shanthappa, Nidheesh Melethadathil, Shiva Prasad Kollur (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12715248.txt.
Description
Human metapneumovirus sends many people, especially children and the elderly, to hospital with respiratory infections, yet no approved drug or vaccine targets it. Pallavi Mosale Shanthappa and co-authors searched for a shortcut: compounds already known to bind the coronavirus behind COVID-19 might also fit this virus. They tested three candidates entirely in computer simulations, docking each into a model of a viral protein and watching the fit over time.
One compound, salvianolic acid C, from a traditional medicinal plant, held on most stably. Its complex stayed steady, kept a regular hydrogen bond in place, and scored the best binding energy of the three. The other two candidates wobbled and bound weakly. The authors nominate salvianolic acid C for laboratory testing as a possible antiviral against this virus.
Catalog record
| CREATOR | Pallavi Mosale Shanthappa, Nidheesh Melethadathil, Shiva Prasad Kollur |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |